Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1930
mi
from 43215
Murrieta, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1930
mi
from 43215
Murrieta, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2017
mi
from 43215
Oxnard, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2017
mi
from 43215
Oxnard, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2062
mi
from 43215
Santa Maria, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2062
mi
from 43215
Santa Maria, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1985
mi
from 43215
Santa Monica, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1985
mi
from 43215
Santa Monica, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1958
mi
from 43215
South Lake Tahoe, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1958
mi
from 43215
South Lake Tahoe, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1911
mi
from 43215
Victorville, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1911
mi
from 43215
Victorville, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1167
mi
from 43215
Lakewood, CO
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1167
mi
from 43215
Lakewood, CO
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
522
mi
from 43215
Trumbull, CT
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
522
mi
from 43215
Trumbull, CT
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
922
mi
from 43215
Fort Myers, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
922
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
976
mi
from 43215
Hollywood, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
976
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
668
mi
from 43215
Jacksonville, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
668
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
810
mi
from 43215
Kissimmee, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
810
mi
from 43215
Kissimmee, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
975
mi
from 43215
Pembroke Pines, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
975
mi
from 43215
Pembroke Pines, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
866
mi
from 43215
Sebring, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
866
mi
from 43215
Sebring, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
393
mi
from 43215
Gainesville, GA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
393
mi
from 43215
Gainesville, GA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
413
mi
from 43215
Woodstock, GA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
413
mi
from 43215
Woodstock, GA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
389
mi
from 43215
Alton, IL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
389
mi
from 43215
Alton, IL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
351
mi
from 43215
Rockford, IL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
351
mi
from 43215
Rockford, IL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
405
mi
from 43215
Bettendorf, IA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
405
mi
from 43215
Bettendorf, IA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from 43215
East Lansing, MI
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from 43215
East Lansing, MI
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
206
mi
from 43215
Lansing, MI
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
206
mi
from 43215
Lansing, MI
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
680
mi
from 43215
Woodbury, MN
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
680
mi
from 43215
Woodbury, MN
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
585
mi
from 43215
Springfield, MO
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
585
mi
from 43215
Springfield, MO
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1767
mi
from 43215
Las Vegas, NV
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1767
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Research Site
461
mi
from 43215
Butler, NJ
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Research Site
461
mi
from 43215
Butler, NJ
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Research Site
449
mi
from 43215
Dover, NJ
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Research Site
449
mi
from 43215
Dover, NJ
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1333
mi
from 43215
Albuquerque, NM
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
505
mi
from 43215
Plainview, NY
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
505
mi
from 43215
Plainview, NY
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from 43215
Asheboro, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from 43215
Asheboro, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
462
mi
from 43215
Tabor City, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
462
mi
from 43215
Tabor City, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
110
mi
from 43215
Akron, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
110
mi
from 43215
Akron, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
65
mi
from 43215
Centerville, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
65
mi
from 43215
Centerville, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
79
mi
from 43215
Middletown, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
79
mi
from 43215
Middletown, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1967
mi
from 43215
Bend, OR
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1967
mi
from 43215
Bend, OR
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
243
mi
from 43215
Duncansville, PA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
243
mi
from 43215
Duncansville, PA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
409
mi
from 43215
Lansdale, PA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
409
mi
from 43215
Lansdale, PA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
487
mi
from 43215
Myrtle Beach, SC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
487
mi
from 43215
Myrtle Beach, SC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
431
mi
from 43215
Jackson, TN
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
431
mi
from 43215
Jackson, TN
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
920
mi
from 43215
Southlake, TX
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
920
mi
from 43215
Southlake, TX
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
428
mi
from 43215
Chesapeake, VA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
428
mi
from 43215
Chesapeake, VA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
335
mi
from 43215
Midlothian, VA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
335
mi
from 43215
Midlothian, VA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
264
mi
from 43215
Winchester, VA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
264
mi
from 43215
Winchester, VA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1778
mi
from 43215
Spokane, WA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1778
mi
from 43215
Spokane, WA
Click here to add this to my saved trials